Compare GBLI & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GBLI | NRC |
|---|---|---|
| Founded | 2016 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.4M | 390.8M |
| IPO Year | 2010 | 1997 |
| Metric | GBLI | NRC |
|---|---|---|
| Price | $28.33 | $17.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.5K | ★ 72.5K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.03% | 3.81% |
| EPS Growth | N/A | ★ 4707.69 |
| EPS | 1.75 | ★ 50.00 |
| Revenue | ★ $450,098,000.00 | $119,686,000.00 |
| Revenue This Year | $14.23 | N/A |
| Revenue Next Year | $9.68 | N/A |
| P/E Ratio | $15.90 | ★ $0.34 |
| Revenue Growth | ★ 2.02 | 1.81 |
| 52 Week Low | $25.88 | $9.76 |
| 52 Week High | $34.00 | $22.79 |
| Indicator | GBLI | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 50.69 | 53.52 |
| Support Level | $27.55 | $16.64 |
| Resistance Level | $28.81 | $18.29 |
| Average True Range (ATR) | 0.28 | 0.74 |
| MACD | 0.05 | -0.11 |
| Stochastic Oscillator | 55.50 | 45.79 |
Global Indemnity Group LLC is a United States-based holding company with a diversified portfolio of property and casualty insurance-related entities. Along with its subsidiaries, the company operates in the following reportable segments: Agency and Insurance Services, Belmont Insurance Companies - Core (Belmont Core), and Belmont Insurance Companies - Non-Core (Belmont Non-Core). Maximum revenue is generated from the Belmont Core segment, which offers direct insurance and assumed reinsurance products in the E&S (Excess and Surplus) marketplace. The Agency and Insurance Services segment is focused on sourcing, underwriting, and servicing primary and assumed reinsurance business; and specialized insurance service businesses providing technology, AI-enabled marketplace, and claims services.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.